Alpha 2.0
Login Register
» Authors » M Hoogendoorn

M Hoogendoorn

Explore the profile of M Hoogendoorn including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 421
Followers 0
Related Specialties
General Medicine
Oncology
Hematology
Top 10 Co-Authors
R E Kibbelaar
M P M H Rutten-van Molken
E N van Roon
J J Cornelissen
S K Klein
B E Oortgiesen
N J G M Veeger
A A van de Loosdrecht
T L Feenstra
A Beeker
Published In
Neth J Med
Ned Tijdschr Geneeskd
Ann Hematol
Eur Respir J
Eur J Cancer
Affiliations
Soon will be listed here.
Recent Articles
1.
Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML Patients
Kockerols C, Valk P, Hogenbirk P, Geelen I, Blijlevens N, Janssen J, et al.
Eur J Haematol . 2025 Feb; PMID: 39957332
Approximately 40%-60% of patients reaching a stable deep molecular response during TKI treatment will maintain a state of remission after TKI discontinuation, denoted as treatment-free remission (TFR). Depth of molecular...
2.
The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapy
Kaplan Z, van Leeuwen N, van Klaveren D, Eijkenaar F, Visser O, Posthuma E, et al.
ESMO Open . 2025 Jan; 10(2):104152. PMID: 39889323
Background: Acute myeloid leukemia (AML) requires specialized care, particularly when administrating intensive remission induction chemotherapy (ICT). High-volume hospitals are presumed more adept at delivering this complex treatment, resulting in better...
3.
Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial
Seefat M, Stege C, Lissenberg-Witte B, Levin M, Timmers G, Hoogendoorn M, et al.
Eur J Cancer . 2024 Jun; 207:114153. PMID: 38870747
Background: Frailty in newly-diagnosed multiple myeloma (NDMM) patients is associated with treatment-related toxicity, which negatively affects health-related quality of life (HRQoL). Currently, data on changes in HRQoL of frail and...
4.
End-to-end learning with interpretation on electrohysterography data to predict preterm birth
Fischer A, Rietveld A, Teunissen P, Bakker P, Hoogendoorn M
Comput Biol Med . 2023 Apr; 158:106846. PMID: 37019011
Prediction of preterm birth is a difficult task for clinicians. By examining an electrohysterogram, electrical activity of the uterus that can lead to preterm birth can be detected. Since signals...
5.
Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells
van Bruggen J, van der Windt G, Hoogendoorn M, Dubois J, Kater A, Peters F
Blood Adv . 2022 May; 6(14):4185-4195. PMID: 35580333
Acquired T-cell dysfunction is characteristic of chronic lymphocytic leukemia (CLL) and is associated with reduced efficacy of T cell-based therapies. A recently described feature of dysfunctional CLL-derived CD8 T cells...
6.
High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study
Oortgiesen B, Kroes J, Scholtens P, Hoogland J, Dannenberg-de Keijzer P, Siemes C, et al.
Support Care Cancer . 2021 Jul; 30(1):271-278. PMID: 34273034
Purpose: Peripheral neuropathy (PN) is common in patients with multiple myeloma (MM). We hypothesized that the relationship between hypovitaminosis D and PN described in diabetes mellitus patients may also be...
7.
Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study
Cruijsen M, van der Velden W, de Haan A, Klein S, Hoogendoorn M, Tromp Y, et al.
Leuk Lymphoma . 2020 Jun; 61(11):2752-2755. PMID: 32530341
No abstract available.
8.
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting
van der Galien H, Hoogendoorn M, Kibbelaar R, van Meerten T, van Rijn R
Ann Oncol . 2018 Oct; 30(1):151-152. PMID: 30364941
No abstract available.
9.
Bridging the gap between the randomised clinical trial world and the real world by combination of population-based registry and electronic health record data: A case study in haemato-oncology
Kibbelaar R, Oortgiesen B, van der Wal-Oost A, Boslooper K, Coebergh J, Veeger N, et al.
Eur J Cancer . 2017 Oct; 86:178-185. PMID: 28992561
Randomised clinical trials (RCTs) are considered the basis of evidence-based medicine. It is recognised more and more that application of RCT results in daily practice of clinical decision-making is limited...
10.
Expanding the clinical spectrum of self-limiting, rare Kikuchi disease - A case with overwhelming multi-organ involvement
Hoogstins H, Kibbelaar R, Ubels F, Hemmelder M, Hoogendoorn M
Neth J Med . 2017 May; 75(3):112-116. PMID: 28469047
Kikuchi disease is a rare disorder with an unknown pathogenesis and a typically self-limiting natural course in predominantly previously healthy young women. Here we present a 54-year-old woman suffering from...